| Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study P Laureati, Y Xu, M Trevisan, L Schalin, I Mariani, R Bellocco, MM Sood, ... Nephrology Dialysis Transplantation 35 (9), 1518-1526, 2020 | 79 | 2020 |
| Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease Y Xu, M Evans, M Soro, P Barany, JJ Carrero Clinical kidney journal 14 (10), 2213-2220, 2021 | 52 | 2021 |
| The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials J Yang, C Huang, S Wu, Y Xu, T Cai, S Chai, Z Yang, F Sun, S Zhan PloS one 12 (12), e0187537, 2017 | 51 | 2017 |
| Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care M Trevisan, EL Fu, Y Xu, G Savarese, FW Dekker, LH Lund, CM Clase, ... European journal of heart failure 23 (10), 1698-1707, 2021 | 44 | 2021 |
| Gastrointestinal adverse events of dipeptidyl peptidase 4 inhibitors in type 2 diabetes: a systematic review and network meta-analysis S Wu, S Chai, J Yang, T Cai, Y Xu, Z Yang, Y Zhang, L Ji, F Sun, S Zhan Clinical Therapeutics 39 (9), 1780-1789. e33, 2017 | 42 | 2017 |
| Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them EL Fu, M van Diepen, Y Xu, M Trevisan, FW Dekker, C Zoccali, K Jager, ... Clinical Kidney Journal 14 (5), 1317-1326, 2021 | 40 | 2021 |
| Glycemic control and the risk of acute kidney injury in patients with type 2 diabetes and chronic kidney disease: parallel population-based cohort studies in US and Swedish … Y Xu, A Surapaneni, J Alkas, M Evans, JI Shin, E Selvin, A Chang, ... Diabetes Care 43 (12), 2975-2982, 2020 | 29 | 2020 |
| The cardiovascular effect of incretin-based therapies among type 2 diabetes: a systematic review and network meta-analysis S Wu, A Cipriani, Z Yang, J Yang, T Cai, Y Xu, X Quan, Y Zhang, S Chai, ... Expert Opinion on Drug Safety 17 (3), 243-249, 2018 | 27 | 2018 |
| Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes Y Xu, EL Fu, M Trevisan, T Jernberg, A Sjölander, CM Clase, JJ Carrero American heart journal 243, 177-186, 2022 | 26 | 2022 |
| Statins use and risk of new-onset diabetes in hypertensive patients: a population-based retrospective cohort study in Yinzhou district, Ningbo city, People’s Republic of China H Li, H Lin, H Zhao, Y Xu, Y Cheng, P Shen, S Zhan Therapeutics and clinical risk management, 823-832, 2018 | 22 | 2018 |
| Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the … Z Ying, Z Jingru, Z Kai, T Sydney, SJ Ross J., K Alan C., X Yang, J Wei, ... Drugs - Real World Outcomes 9 (2), 231-241, 2022 | 17 | 2022 |
| GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes Y Xu, EL Fu, CM Clase, F Mazhar, MJ Jardine, JJ Carrero Kidney International 101 (2), 360-368, 2022 | 15 | 2022 |
| The seasonality of acute attack of primary angle-closure glaucoma in Beijing, China J Zhu, Y Xu, H Wang, D Liu, J Zhu, H Wu Scientific Reports 8 (1), 4036, 2018 | 14 | 2018 |
| Sulphonylureas monotherapy and risk of hospitalization for heart failure in patients with type 2 diabetes mellitus: A population‐based cohort study in China Y Xu, T Wang, Z Yang, H Lin, P Shen, S Zhan Pharmacoepidemiology and Drug Safety 29 (6), 635-643, 2020 | 12 | 2020 |
| Burden and causes of hospital admissions and readmissions in patients undergoing hemodialysis and peritoneal dialysis: a nationwide study Y Xu, L Li, M Evans, H Xu, B Lindholm, JJ Carrero Journal of Nephrology 34 (6), 1949-1959, 2021 | 10 | 2021 |
| Long-Term Patterns of Antidiabetic Medication Use in Patients with Type 2 Diabetes Y Xu, Z Yang, H Lin, P Shen, H Wang, S Zhan Medical science monitor : international medical journal of experimental and …, 2018 | 10 | 2018 |
| Pharmacologic treatment of type 2 diabetes in the US, Sweden, and Israel B Lyu, Y Sang, E Selvin, AR Chang, GC Alexander, CM Cohen, J Coresh, ... Diabetes care 45 (12), 2926-2934, 2022 | 9 | 2022 |
| Association between reduced kidney function and incident hypoglycaemia in people with diabetes: The Stockholm Creatinine Measurements (SCREAM) project B Runesson, Y Xu, AR Qureshi, B Lindholm, P Barany, CG Elinder, ... Diabetes, Obesity and Metabolism 22 (8), 1425-1435, 2020 | 9 | 2020 |
| Pharmacoepidemiology for nephrologists (part 1): concept, applications and considerations for study design M Trevisan, EL Fu, Y Xu, K Jager, C Zoccali, FW Dekker, JJ Carrero Clinical Kidney Journal 14 (5), 1307-1316, 2021 | 8 | 2021 |
| Factors affecting pre-end-stage kidney disease haemoglobin control and outcomes following dialysis initiation: a nationwide study Y Xu, M Evans, P Barany, G James, A Sjölander, JJ Carrero Clinical Kidney Journal 14 (7), 1780-1788, 2021 | 4 | 2021 |
